Hausdorff W P, Campbell P T, Ostrowski J, Yu S S, Caron M G, Lefkowitz R J
Department of Medicine, Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC 27710.
Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):2979-83. doi: 10.1073/pnas.88.8.2979.
Plasma membrane receptors that couple to guanine nucleotide-binding regulatory proteins (G proteins) undergo a variety of rapid (minutes) and longer term (hours) regulatory processes induced by ligands. For the beta 2-adrenergic receptor (beta 2AR), the rapid processes include functional desensitization, mediated by phosphorylation of the receptor by the cAMP-dependent protein kinase and the beta-adrenergic receptor kinase, as well as a loss of hydrophilic ligand binding proposed to represent sequestration of receptors into a cellular compartment distinct from the plasma membrane. The slower processes include beta 2AR down-regulation (i.e., a decrease in the total cellular complement of receptors). It is not yet known whether beta 2AR phosphorylation and/or sequestration are prerequisites for down-regulation of the receptor. Like other G protein-coupled receptors, the beta 2AR molecule spans the plasma membrane seven times, and the cytoplasmic carboxyl-terminal domain has been proposed to contain molecular determinants for each of these regulatory processes. We replaced four serine and threonine residues located within a 10-amino acid segment of this domain of beta 2AR and thereby prevented agonist-promoted phosphorylation, sequestration, and rapid desensitization of the adenylyl cyclase response. In contrast, these mutations did not affect functional coupling to the stimulatory G protein Gs or long-term down-regulation. These findings thus define a small, hitherto unappreciated region of the receptor molecule that may selectively subserve its rapid regulation. In addition, with the demonstration that beta 2AR does not have to be phosphorylated or sequestered in order to enter the down-regulation pathway, the results suggest that the classical receptor endocytosis model may not be appropriate for beta 2AR regulation.
与鸟嘌呤核苷酸结合调节蛋白(G蛋白)偶联的质膜受体,会经历由配体诱导的各种快速(数分钟)和长期(数小时)调节过程。对于β2肾上腺素能受体(β2AR),快速过程包括功能性脱敏,这是由cAMP依赖性蛋白激酶和β肾上腺素能受体激酶对受体进行磷酸化介导的,以及亲水性配体结合的丧失,这被认为代表受体被隔离到一个与质膜不同的细胞区室中。较慢的过程包括β2AR下调(即受体的总细胞量减少)。目前尚不清楚β2AR磷酸化和/或隔离是否是受体下调的先决条件。与其他G蛋白偶联受体一样,β2AR分子跨质膜七次,并且有人提出细胞质羧基末端结构域包含这些调节过程中每一个的分子决定因素。我们替换了β2AR该结构域10个氨基酸片段内的四个丝氨酸和苏氨酸残基,从而防止了激动剂促进的磷酸化、隔离以及腺苷酸环化酶反应的快速脱敏。相比之下,这些突变并不影响与刺激性G蛋白Gs的功能偶联或长期下调。因此,这些发现定义了受体分子中一个小的、迄今未被重视的区域,该区域可能选择性地参与其快速调节。此外,由于证明β2AR进入下调途径不一定需要磷酸化或隔离,结果表明经典的受体内吞作用模型可能不适用于β2AR调节。